Overview
- 60 inspections across 53 sites are on record.
- 98 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2016-07-08.
At a glance
Inspections
60
Sites
53
Observations
98
Career since
Mar 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Genentech, Inc. | 8 Jul 2016 | Human Drugs | View 483 → |
| Bell-More Labs, Inc. | 26 May 2016 | Human Drugs | View 483 → |
| GlaxoSmithKline LLC | 21 Apr 2016 | Human Drugs | View 483 → |
| Baxter Healthcare Corporation | 26 Feb 2016 | Human Drugs | View 483 → |
| Biogen MA Inc. | 15 Jan 2016 | Human Drugs |
Sites inspected
Genentech, Inc.South San Francisco, United States1 insp.
Bell-More Labs, Inc.Hampstead, United States1 insp.
GlaxoSmithKline LLCZebulon, United States1 insp.
Baxter Healthcare CorporationMarion, United States1 insp.
Biogen MA Inc.Research Triangle Park, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Stephanie A Slater3 shared
Anh Lac3 shared
Heika R Tait3 shared
Jonathan W Chapman2 shared
Jose F Velez2 shared
Latorie S Jones2 shared
Russell K Riley2 shared
Sangeeta M Khurana2 shared
Daniel J Roberts2 shared
Raquel Gonzalez Rivera2 shared
Full investigator report
Get the verbatim findings behind Rebecca Rodriguez's 98 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site